e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
What's new in tobacco and lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Susceptibility to tobacco smoke related to protease inhibitor PIM subtypes in COPD
M. Gambaryan, N. Didkovsky, A. Kalinina, A. Deev (Moscow, Russian Federation)
Source:
Annual Congress 2005 - What's new in tobacco and lung disease
Session:
What's new in tobacco and lung disease
Session type:
Oral Presentation
Number:
3055
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Gambaryan, N. Didkovsky, A. Kalinina, A. Deev (Moscow, Russian Federation). Susceptibility to tobacco smoke related to protease inhibitor PIM subtypes in COPD. Eur Respir J 2005; 26: Suppl. 49, 3055
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Environmental tobacco smoke exposure and the risk of obstructive lung disease exacerbation
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005
Beyond personal smoking: does environmental tobacco smoke cause chronic obstructive pulmonary disease?
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005
Overview of smoking-related disease
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Passive and active smoking in childhood for COPD
Source: Annual Congress 2005 - Does COPD begin in childhood? Reviewing the evidence
Year: 2005
Tobacco smoke and respiratory disease
Source: ISSN=1025-448x, ISBN=1-904097-24-3, page=161
Year: 2002
Tobacco use in relation to COPD and asthma
Source: Eur Respir J 2007; 29: 438-445
Year: 2007
COPD in Chinese nonsmokers
Source: Eur Respir J 2009; 33: 509-518
Year: 2009
Environmental tobacco smoke and health in the elderly
Source: Eur Respir J 2002; 19: 172-181
Year: 2002
Introduction on epidemiological evidence for the early onset of COPD
Source: Annual Congress 2005 - Does COPD begin in childhood? Reviewing the evidence
Year: 2005
Wood smoke exposure and risk of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 27: 542-546
Year: 2006
Effect of 1-year smoking cessation on matrix-metalloproteinases and their inhibitors in COPD
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006
Evidence for harm reduction in diseased smokers
Source: Annual Congress 2007 - Targeting smokers by reduction: the "snus" connection revisited
Year: 2007
Workplace smoking restriction and respiratory health: the Irish experience
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005
CTLA4 gene polymorphisms are associated with chronic bronchitis
Source: Eur Respir J 2009; 34: 598
Year: 2009
Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Impact of cigarette smoke exposure on host–bacterial pathogen interactions
Source: Eur Respir J 2012; 39: 467-477
Year: 2012
Epidemiology of COPD
Source: Eur Respir Rev 2009; 18: 213-221
Year: 2009
Smoking cessation in patients with respiratory diseases
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005
COPD patients‘ response to smoking cessation
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept